The effect of twice daily controlled-releasing salbutamol tablets (Salbutamol CR=Volmax) in chronic obstructive pulmonary disease KRONIK OBSTRUKTIF AKCIGER HASTALIGININ TEDAVISINDE GUNLUK IKI DOZ HALINDE VERILEN, KONTROLLU SALIVERILEN SALBUTAMOL TABLETIN (SALBUTAMOL CR=VOLMAX) ETKISI


KÖYLÜ R., Bilgic H., Ekiz K., Tozkoparan E.

Bulletin of Gulhane Military Medical Academy, cilt.37, sa.3, ss.310-313, 1995 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 3
  • Basım Tarihi: 1995
  • Dergi Adı: Bulletin of Gulhane Military Medical Academy
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.310-313
  • Anahtar Kelimeler: Chronic obstructive lung disease, Volmax
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Various drug groups are being used to treat chronic obstructive pulmonary disease. Agonists of β-2 receptors have an important role in this treatment. In this study, we investigate the efficacy and security of controlled-releasing salbutamol tablets (volmax) in a series of 25 cases. As a conclusion, we can say that volmax provides an effective bronchodilatation and has minimal side effects. It can be used singly in selected patients and combining with other drug in complicated cases.